Supporting CROs by redefining patient engagement, from clinical to real-world studies for improved outcomes

Meet us at DIA 2022 to find out more about our CRO Partner

As patient engagement experts, we understand the challenges the CROs face when it comes to patient engagement and gathering better data for improved outcomes. Our patient-first approach is proven to increase patient engagement in up to 91% of research patients. If you are conducting a clinical trial where patient engagement is critical to the success of the study, why not book an appointment to speak to our Director of Business Development, Rebecca Davis, who will be on hand at this years DIA Annual Meeting to provide a demonstration of our next-generation eCOA platform, TrialMotif.  

TrialMotif™, is powering site-based to fully decentralized trials – from the most simple, to the most complex. Our patient-centric platform enables sponsors to continuously engage and capture every patient (data) experience, via beautifully designed technology, throughout the life cycle of the research process.

We have a track record of supporting global CROs to deliver better clinical data. Our latest sleep study delivered:

• 190,000 hours of sleep data
• 160,000 symptoms
• 9,000 sleep diaries

If you’re interested in learning more about TrialMotif™, schedule some time to meet Rebecca either at the DIA Annual Meeting, or virtually:
rebecca.davis@umotif.com
843-991-7240.